Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

Cited by (999)

Items 901–999 of 999

  1. The Chinese Prescription Wen-Pi-Tang Extract Delays Disease Onset in Amyotrophic Lateral Sclerosis Model Mice While Attenuating the Activation of Glial Cells in the Spinal Cord
    Michiko Sekiya, Takashi Ichiyanagi, Yasumasa Ikeshiro, Takako Yokozawa · 2009 · Biological and Pharmaceutical Bulletin
  2. Exercise induces metallothioneins in mouse spinal cord
    Kazunori Hashimoto, Yuichi Hayashi, Takashi Inuzuka, Isao Hozumi · 2009 · Neuroscience
  3. Ligand-independent activation of the P2X7 receptor by Hsp90 inhibition stimulates motor neuron apoptosis
    Amy L. Strayer, Cassandra N. Dennys, Karina C. Ricart, Narae Bae, Joseph S. Beckman, María Clara Franco, Álvaro G. Estévez · 2019 · Experimental Biology and Medicine
  4. Mutant SOD1 microglia-generated nitroxidative stress promotes toxicity to human fetal neural stem cell-derived motor neurons through direct damage and noxious interactions with astrocytes.
    Jason R. Thonhoff, Junling Gao, Tiffany J. Dunn, Luis D. Ojeda, Ping Wu · 2012 · Europe PMC (PubMed Central)
  5. Proteome alteration of U251 human astrocytoma cell after inhibiting retinoic acid synthesis
    Min Zhang, Chunling Wan, Baohu Ji, Zhao Zhang, Hui Zhu, Nan Tian, Yujuan La, Ke Huang, Lei Jiang, Guang He et al. · 2008 · Molecular and Cellular Biochemistry
  6. Telmisartan is neuroprotective in a hiPSC-derived spinal microtissue model for C9orf72 ALS via inhibition of neuroinflammation
    Berkiye Sonustun, Björn Friedhelm Vahsen, Mario Ledesma-Terrón, Zhuoning Li, Laura Tuffery, Nan Xu, Elizabeth L. Calder, Johannes Jungverdorben, Leslie Weber, Aaron Zhong et al. · 2025 · Stem Cell Reports
  7. Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model
    Benjamin Darcy Rowlands, Benjamin Guy Trist, Connor Karozis, Greta Schaffer, David Mor, Richard Harwood, Sarah Alyssa Rosolen, Veronica Cottam, Freyja Persson-Carboni, Miriam Richardson et al. · 2025 · Acta Neuropathologica Communications
  8. 4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice
    Leenor Alfahel, Shirel Argueti-Ostrovsky, Shir Barel, Mahmood Ali Saleh, Joy Kahn, Salome Azoulay‐Ginsburg, Ayelet Rothstein, Simon Ebbinghaus, Arie Gruzman, Adrian Israelson · 2022 · International Journal of Molecular Sciences
  9. Stem Cell Interventions in Neurology: From Bench to Bedside
    Miguel A. Pappolla, Ping Wu, Xiang Fang, Burkhard Pöeggeler, Kumar Sambamurti, Thomas Wısnıewskı, George L. Perry · 2024 · Journal of Alzheimer s Disease
  10. Neuronal death signaling pathways triggered by mutant LRRK2
    Hardy J. Rideout · 2017 · Biochemical Society Transactions
  11. Immune-microbiome interplay and its implications in neurodegenerative disorders
    Ankit Uniyal, Vineeta Tiwari, Mousmi Rani, Vinod Tiwari · 2021 · Metabolic Brain Disease
  12. Impact of Plant-Derived Compounds on Amyotrophic Lateral Sclerosis
    Lucas Matheus Gonçalves de Oliveira, Rodrigo Barreto Carreira, Juciele Valéria Ribeiro de Oliveira, Ravena Pereira do Nascimento, Cleide Dos Santos Souza, Emiliano Trías, Víctor Diógenes Amaral da Silva, Sílvia Lima Costa · 2023 · Neurotoxicity Research
  13. The Ying and Yang of Hydrogen Sulfide as a Paracrine/Autocrine Agent in Neurodegeneration: Focus on Amyotrophic Lateral Sclerosis
    Alida Spalloni, Susanna De Stefano, Juliette Gimenez, Viviana Greco, Nicola Biagio Mercuri, Valerio Chiurchiù, Patrizia Longone · 2023 · Cells
  14. Blockade of mGluR5 in astrocytes derived from human iPSCs modulates astrocytic function and increases phagocytosis
    Izabella B. Q. de Lima, Pablo Leal Cardozo, Júlia S. Fahel, Juliana P. S. Lacerda, Aline Silva de Miranda, Antônio Lúcio Teixeira, Fabiola Mara Ribeiro · 2023 · Frontiers in Immunology
  15. Is Amyotrophic Lateral Sclerosis a Mitochondrial Channelopathy?
    Virginia Le Verche, Serge Przedborski · 2010 · Neuron
  16. The Promise and Therapeutic Potential of Human ES and iPS Cells
    Shi‐Jiang Lu, Randall J. Lee, Claudio Napoli A, Steve K. W. Oh, Erin A. Kimbrel, Qiang Feng · 2011 · Stem Cells International
  17. Amyotrophic lateral sclerosis: applications of stem cells – an update
    Lidia Cova, Vincenzo Silani · 2010 · Stem Cells and Cloning Advances and Applications
  18. Embryonic and Induced Pluripotent Stem Cells as a Model for Liver Disease
    Hiroshi Yagi, Edgar N. Tafaleng, Masaki Nagaya, Marc C. Hansel, Stephen C. Strom, Ira J. Fox, Alejandro Soto–Gutiérrez · 2009 · Critical Reviews in Biomedical Engineering
  19. The effect of amyotrophic lateral sclerosis-linked exogenous SOD1-G93A on electrophysiological properties and intracellular calcium in cultured rat astrocytes
    Milena M. Milosevic, Danijela Bataveljić, Ljiljana M. Nikolic, Dunja D. Bijelić, Pavle R. Anđjus · 2016 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  20. Patient‐derived olfactory mucosa for study of the non‐neuronal contribution to amyotrophic lateral sclerosis pathology
    Vega García‐Escudero, María Rosales, José Luis Muñoz, Esteban Scola, Javier Medina, Hena Khalique, Guillermo Garaulet, Antonio Rodrı́guez, Filip Lim · 2015 · Journal of Cellular and Molecular Medicine
  21. Gemals, a new drug candidate, extends lifespan and improves electromyographic parameters in a rat model of amyotrophic lateral sclerosis
    Charles Nicaise, J Coupier, Marie‐Pierre Dabadie, Robert De Decker, Arturo Mangas, D. Bodet, Luc Poncelet, M. Geffard, Roland Pochet · 2008 · Amyotrophic Lateral Sclerosis
  22. Improved synthesis and application of an alkyne-functionalized isoprenoid analogue to study the prenylomes of motor neurons, astrocytes and their stem cell progenitors
    Kiall F. Suazo, Vartika R. Mishra, Sanjay Maity, Shelby A. Auger, Katarzyna Justyna, Alexandru Mihai Petre, Linda Ottoboni, Jessica Ongaro, Stefania Paola Corti, Francesco Lotti et al. · 2024 · Bioorganic Chemistry
  23. Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7
    Myriam Torres-Rico, Virginia García-Calvo, Adrián Gironda-Martínez, Jorge Pascual-Guerra, Antonio G. Garcı́a, Victoria Maneu · 2024 · Cell Calcium
  24. TNFα prevents FGF4-mediated rescue of astrocyte dysfunction and reactivity in human ALS models
    Erika Velásquez, Ekaterina Savchenko, Sara Marmolejo-Martínez-Artesero, Désiré Challuau, Aline Aebi, Yuriy Pomeshchik, Nuno Jorge Lamas, Mauno Vihinen, Melinda Rezeli, Bernard Laurent Schneider et al. · 2024 · Neurobiology of Disease
  25. Increased plasma lipocalin‐2 levels are associated with nonmotor symptoms and neuroimaging features in patients with Parkinson's disease
    Yongyan Fan, Xiaohuan Li, Jianjun Ma, Dawei Yang, Keke Liang, Yu Ming Shen, Wei Wei, Linrui Dong, Chuanze Liu, Zonghan She et al. · 2024 · Journal of Neuroscience Research
  26. Deciphering the spectrum of astrocyte diversity: Insights into molecular, morphological, and functional dimensions in health and neurodegenerative diseases
    Fumito Endo · 2024 · Neuroscience Research
  27. Animal Models for Neurodegenerative Disorders
    Hitomi Tsuiji, Koji Yamanaka · 2013 · Elsevier eBooks
  28. Profiling of the dynamically alteredgene expression in peripheral nerve injury using NGS RNA sequencing technique.
    Duanyang Han, Yixun Chen, Yuhui Kou, Jian Weng, Bo Chen, Youlai Yu, Peixun Zhang, Baoguo Jiang · 2016 · PubMed Central
  29. Connexin 30 Deficiency Ameliorates Disease Progression at the Early Phase in a Mouse Model of Amyotrophic Lateral Sclerosis by Suppressing Glial Inflammation
    Yu Hashimoto, Ryo Yamasaki, Senri Ko, Eriko Matsuo, Yuko Kobayakawa, Katsuhisa Masaki, Dai Matsuse, Noriko Isobe · 2022 · International Journal of Molecular Sciences
  30. Selective Vulnerability of Neuronal Subtypes in ALS: A Fertile Ground for the Identification of Therapeutic Targets
    Cylia Rochat, Nathalie Bernard‐Marissal, Bernard Laurent Schneider · 2016 · InTech eBooks
  31. DHPLC can be used to detect low-level mutations in amyotrophic lateral sclerosis
    Natasha Luquin, Bing Yu, Ronald J. Trent, Roger Pamphlett · 2010 · Amyotrophic Lateral Sclerosis
  32. Glial Cells in ALS: The Missing Link?
    Elsa Raibon, Lisa Marie Todd, Thomas Möller · 2008 · Physical Medicine and Rehabilitation Clinics of North America
  33. Mouse embryonic stem cell‐derived motor neurons are susceptible to ferroptosis
    Alejandra M. Martinez, Ahryun Kim, Cristina Aguilar Flores, Daoud F. Rahman, Wan Seok Yang · 2023 · FEBS Open Bio
  34. Potential contribution of spinal interneurons to the etiopathogenesis of amyotrophic lateral sclerosis
    Luca Goffin, Damien Lemoine, Frédéric Clotman · 2024 · Frontiers in Neuroscience
  35. Genetic Basis of Motor Neuron Diseases: Insights, Clinical Management, and Future Directions
    Apostolos Antonakoudis, Stella Aikaterini Kyriakoudi, Despoina Chatzi, Iasonas Dermitzakis, Sofia Gargani, Soultana Meditskou, Maria Eleni Μanthou, Paschalis Theotokis · 2025 · International Journal of Molecular Sciences
  36. In vivo self-assembled SOD1-siRNAs mitigate muscle atrophy and denervation in amyotrophic lateral sclerosis
    Jingwei Guo, Qian Zou, Jiawei Xu, Jieqiong Lei, Xin Yin, Botao Li, Jinyu Fu, Jintao Mi, Yanbo Wang, Huan Huang et al. · 2025 · Brain
  37. Glial Cells as Key Mediators in the Pathophysiology of Neurodegenerative Diseases
    Katarzyna Bogus, Nicoletta Marchesi, Lucrezia Irene Maria Campagnoli, Alessia Pascale, Artur Pałasz · 2026 · International Journal of Molecular Sciences
  38. The Essential Role of Astrocytes in Neurodegeneration and Neuroprotection
    Federico López Couselo, Julieta Saba, Lila Carniglia, Daniela Durand, Mercedes Lasaga, Carla M. Caruso · 2023 · CNS & Neurological Disorders - Drug Targets
  39. Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation
    Irina V. Utkina-Sosunova, A Chiorazzi, Mariangels De Planell-Saguer, Hai Li, C Meregalli, E Pozzi, Valentina Carozzi, A Canta, Laura Monza, Paola Alberti et al. · 2024 · Scientific Reports
  40. Experimental and Therapeutic Opportunities for Stem Cells in Multiple Sclerosis
    Rickie Patani, Siddharthan Chandran · 2012 · International Journal of Molecular Sciences
  41. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons
    Sara D. Qi, Paul D. Smith, Peter Choong · 2014 · ANZ Journal of Surgery
  42. P2X4 signalling contributes to hyperactivity but not pain sensitization comorbidity in a mouse model of attention deficit/hyperactivity disorder
    Sarah Bou Sader Nehme, Sandra Sánchez‐Sarasúa, Ramy Adel, Marie Tuifua, Awatef Mohamed Ali, Amina E. Essawy, Shérine Abdel Salam, Walid Hleihel, Éric Boué‐Grabot, Marc Landry · 2024 · Frontiers in Pharmacology
  43. Unravelling the Road to Recovery: Mechanisms of Wnt Signalling in Spinal Cord Injury
    Suchita Ganesan, Arun Dharmarajan, G. Sudhir, Lakshmi Revathi Perumalsamy · 2024 · Molecular Neurobiology
  44. Sclérose latérale amyotrophique, jonction neuromusculaire et déficit énergétique
    Luc Dupuis, Jean‐Philippe Loeffler · 2008 · médecine/sciences
  45. Modulation of Synaptic Transmission and Analysis of Neuroprotective Effects of Valproic Acid and Derivates in Rat Embryonic Motoneurons
    Daniela Ragancokova, Yunping Song, Heinz Nau, Reinhard Dengler, K. Krampfl, Susanne Petri · 2010 · Cellular and Molecular Neurobiology
  46. Motoneuron Disease: Basic Science
    Hristelina S. Ilieva, Nicholas John Maragakis · 2017 · Advances in neurobiology
  47. Modeling neuromuscular junctions in vitro: A review of the current progress employing human induced pluripotent stem cells
    Lilian A. Patrón, ICAGEN, 2090 E. Innovation Park Dr., Oro Valley, Arizona USA 85755, Paul R. August · 2018 · AIMS Cell and Tissue Engineering
  48. Ablation of interleukin-19 improves motor function in a mouse model of amyotrophic lateral sclerosis
    Hiroyasu Komiya, Hideyuki Takeuchi, Yuki Ogawa, Kosuke Suzuki, Akihiro Ogasawara, Keita Takahashi, Yasu‐Taka Azuma, Hiroshi Doi, Fumiaki Tanaka · 2021 · Molecular Brain
  49. Pathogenesis of amyotrophic lateral sclerosis
    Magdalena Kuźma‐Kozakiewicz · 2011 · Biomedical Reviews
  50. Switching the Proteolytic System from the Ubiquitin–Proteasome System to Autophagy in the Spinal Cord of an Amyotrophic Lateral Sclerosis Mouse Model
    Koh Tadokoro, Toru Yamashita, Jingwei Shang, Yasuyuki Ohta, Emi Nomura, Ryuta Morihara, Yoshio Omote, Mami Takemoto, Koji Abe · 2021 · Neuroscience
  51. Molecular Mechanisms of Neuronal Death
    Elena M. Ribé, Lianna Heidt, Nike T. Beaubier, Carol M. Troy · 2010 · Advances in neurobiology
  52. Les cellules gliales
    Séverine Boillée, Christian S. Lobsiger · 2008 · médecine/sciences
  53. Translational Research in ALS
    Jacqueline Montes, Caterina Bendotti, Massimo Tortarolo, Cristina Cheroni, Hussein Hallak, Zipora Speiser, Sari Goren, Eran Blaugrund, Paul H. Gordon · 2008 · Elsevier eBooks
  54. The state of the art in stem cell biology and regenerative medicine: the end of the beginning
    Evan Y. Snyder · 2017 · Pediatric Research
  55. Boldine as a neuroprotective agent against motor neuron degeneration in models of amyotrophic lateral sclerosis
    Carlos A. Toro, Wei Zhao, Patricio Garcia Silva, Daniela Retamal-Santibáñez, Fabiola Rojas, Jiangping Pan, Nicholas Johnson, Yorley Duarte, Christopher P. Cardozo, Juan Carlos Sáez et al. · 2025 · Frontiers in Cellular Neuroscience
  56. Stem cell-derived brainstem mouse astrocytes obtain a neurotoxic phenotype in vitro upon neuroinflammation
    Caroline Lindblad, Susanne Neumann, Sólrún Kolbeinsdóttir, Vasilios Zachariadis, Eric Peter Thelin, Martin Enge, Sebastian Thams, Lou Brundin, Mikael A. Svensson · 2023 · Journal of Inflammation
  57. Neuroprotection by upregulation of the major histocompatibility complex class I (MHC I) in SOD1G93A mice
    Ana Laura Midori Rossi Tomiyama, Luciana Politti Cartarozzi, Lilian de Oliveira Coser, Gabriela Bortolança Chiarotto, Alexandre Leite Rodrigues de Oliveira · 2023 · Frontiers in Cellular Neuroscience
  58. TDP-43 pathology in Drosophila induces glial-cell type specific toxicity that can be ameliorated by knock-down of SF2/SRSF1
    Sarah Krupp, Isabel Hubbard, Oliver H. Tam, Molly Hammell, Josh Dubnau · 2023 · PLoS Genetics
  59. Glycolysis-Driven Prognostic Model for Acute Myeloid Leukemia: Insights into the Immune Landscape and Drug Sensitivity
    Rongsheng Zhang, Wen Yi Jin, Kankan Wang · 2025 · Biomedicines
  60. Advantages and Pitfalls in Experimental Models Of ALS
    Marina Boido, Elisa Buschini, Antonio Piras, Giada Spigolon, Valeria Valsecchi, Letizia Mazzini, Alessandro Vercelli · 2012 · InTech eBooks
  61. Wild-type but not mutant SOD1 transgenic astrocytes promote the efficient generation of motor neuron progenitors from mouse embryonic stem cells
    Yiota A Christou, Kyoji Ohyama, Marysia Placzek, Peter N. Monk, Pamela J. Shaw · 2013 · BMC Neuroscience
  62. A Neuroanatomical Approach to Exploring Organizational Performance
    David Gillingwater B, Thomas Henry Gillingwater · 2011 · Apple Academic Press eBooks
  63. Contributions of Different Cell Types to Spinal Muscular Atrophy Pathogenesis
    Marc‐Olivier Deguise, Teresa N. Patitucci, Allison D. Ebert, Christian L. Lorson, Rashmi Kothary · 2016 · Elsevier eBooks
  64. Neuroinflammation in amyotrophic lateral sclerosis
    Fumito Endo, Koji Yamanaka · 2014 · Rinsho Shinkeigaku
  65. Current nano/biotechnological approaches in amyotrophic lateral sclerosis
    Inhee Choi, Elizabeth H. Lee, Luke P. Lee · 2013 · Biomedical Engineering Letters
  66. Amyotrophic lateral sclerosis: mechanisms and therapeutic strategies
    Ludo Van Den Bosch · 2017 · Elsevier eBooks
  67. Amyotrophic Lateral Sclerosis
    Owen M. Peters, Robert H. Brown · 2014 · Elsevier eBooks
  68. ALS: astrocytes take center stage, but must they share the spotlight?
    Andrew B. Knott, Ella Bossy‐Wetzel · 2007 · Cell Death and Differentiation
  69. The emerging role of cellular senescence in amyotrophic lateral sclerosis
    Xingli Tan, Naiyong Gao · 2025 · Frontiers in Neuroscience
  70. Novel Dual Mechanism GRT-X Agonist Acting on Kv7 Potassium Channel/Translocator Protein Receptor Prevents Motoneuron Degeneration Following Exposure to Mouse and Human Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Astrocyte-Conditioned Media
    Vera M. Masegosa, Elsa Fritz, Daniela Corvalán, Fabiola Rojas, Polett Garcés, Xavier Navarro, Petra Bloms‐Funke, Brigitte van Zundert, Mireia Herrando‐Grabulosa · 2025 · ACS Chemical Neuroscience
  71. Polyphenols and Stem Cells for Neuroregeneration in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
    Shweta Goyal, Brashket Seth, Rajnish Kumar Chaturvedi · 2021 · Current Pharmaceutical Design
  72. Inhibition of PHLDA3 expression in human superoxide dismutase 1-mutant amyotrophic lateral sclerosis astrocytes protects against neurotoxicity
    Kornélia Szebényi, Ingrid Vargová, Veselina Petrova, Jana Turečková, George M. Gibbons, Monika Řehořová, Mai Abdelgawad, Alexandra Sándor, Dana Mareková, Jessica C. F. Kwok et al. · 2024 · Brain Communications
  73. Human Pluripotent Stem Cells Modeling Neurodegenerative Diseases
    Roxana Nat, Andreas Eigentler, Georg Dechant · 2013 · InTech eBooks
  74. The Neuroinflammation in the Physiopathology of Amyotrophic Lateral Sclerosis
    Mélissa Bowerman, Thierry Vincent, Frédérique Scamps, William Camu, Cdric Raoul · 2013 · InTech eBooks
  75. Using human pluripotent stem cells to study post-transcriptional mechanisms of neurodegenerative diseases
    Rickie Patani, Christopher R. Sibley, Siddharthan Chandran, Jernej Ule · 2012 · Brain Research
  76. Stem Cells may Beat Riluzole in Treatment of Amyotrophic Lateral Sclerosis
    Troy Thomas · 2014 · Journal of Neurological Disorders
  77. Taking Cellular Heterogeneity Into Consideration When Modeling Astrocyte Involvement in Amyotrophic Lateral Sclerosis Using Human Induced Pluripotent Stem Cells
    Stefano Stifani · 2021 · Frontiers in Cellular Neuroscience
  78. A Glutamate Scavenging Protocol Combined with Deanna Protocol in SOD1-G93A Mouse Model of ALS
    Christopher Q. Rogers, Melissa Ramirez, Carol S. Landon, Janine M. DeBlasi, Andrew Paul Koutnik, Csilla Ari, Dominic P. D’Agostino · 2023 · Nutrients
  79. Early nuclear phenotypes and reactive transformation in human iPSC ‐derived astrocytes from ALS patients with SOD1 mutations
    Vincent Soubannier, Mathilde Chaineau, Lale Gursu, Sarah Lépine, David Kalaydjian, Julien Sirois, Ghazal Haghi, Guy Armand Rouleau, Thomas M. Durcan, Stefano Stifani · 2024 · Glia
  80. Mechanizmy patogenetyczne stwardnienia bocznego zanikowego
    Joanna Iłżecka · 2012 · DOAJ (DOAJ: Directory of Open Access Journals)
  81. Experimental spinal cord injury : Development of protection and repair strategies in rats
    Matthias Erschbamer · 2007 · Figshare
  82. Brain-Penetrant NF-κB and NLRP3 Targeting Nanoligomers are Therapeutic in Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s Disease (AD) Human Organoid and Mouse Models
    Sadhana Sharma, Devin Wahl, Sydney J. Risen, Vincenzo S. Gilberto, Anushree Chatterjee, Julie A. Moreno, Thomas J. LaRocca, Prashant Nagpal · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  83. The Innate Immune System in CNS Diseases; Overview
    Federico Montini, Howard L. Weiner · 2024 · Elsevier eBooks
  84. Neuroglia in neurodegeneration: Amyotrophic lateral sclerosis and frontotemporal dementia
    Fabiola De Marchi, Edoardo Gioele Spinelli, Caterina Bendotti · 2025 · Handbook of clinical neurology
  85. C9orf72 Repeat Expansion Induces Metabolic Dysfunction in Human iPSC ‐Derived Microglia and Modulates Glial‐Neuronal Crosstalk
    Marika Mearelli, Insa Hirschberg, Christin Weissleder, Carmela Giachino, Maria Jose Perez J., Malvina Dubroux, Francesca Provenzano, Mafalda Rizzuti, Linda Ottoboni, Udit Sheth et al. · 2025 · Glia
  86. Immune imbalance between T helper 1, T helper 17 and regulatory T cells fuels amyotrophic lateral sclerosis pathogenesis: disease trajectory, diagnosis and therapeutic implications
    Chloe Sligar, Ronald Sluyter, Lezanne Ooi · 2026 · Journal of Neuroinflammation
  87. The Fault in Our Astrocytes - cause or casualties of proteinopathies of ALS/FTD and other neurodegenerative diseases?
    Lynette M. Bustos, Rita Sattler · 2023 · Frontiers in Molecular Medicine
  88. Pathophysiology of Vesicle Dynamics in Astrocytes
    N. Vardjan, M. Potokar, M. Stenovec, Jernej Jorgačevski, S. Trkov, M. Kreft, R. Zorec · 2014 · Springer eBooks
  89. 1980-2011: Parkinson's Disease and Advance in Stem Cell Research
    Lidia Cova, Marie‐Thérèse Armentero · 2011 · InTech eBooks
  90. Nécroptose des motoneurones dans des modèles de sclérose latérale amyotrophique familiale ou sporadique
    Virginia Le Verche · 2014 · médecine/sciences
  91. Classic Studies on the Potential of Stem Cell Neuroregeneration
    Vivek Verma, Keerthana Samanthapudi, Ratujit Raviprakash · 2015 · Journal of the History of the Neurosciences
  92. Inflammasome-Mediated Inflammation in Neurodegenerative Diseases
    Jun Young Park, Yeo Wool Kang, Won Gil Cho · 2019 · The Open Neurology Journal
  93. Targeting Macrophage for the Treatment of Amyotrophic Lateral Sclerosis
    Lian Li, Jie Liu, Hua She · 2019 · CNS & Neurological Disorders - Drug Targets
  94. Induced pluripotent stem cell technology: venturing into the second decade
    Yanhong Shi, Haruhisa Inoue, Jun B. Takahashi, Shinya Yamanaka · 2020 · Elsevier eBooks
  95. Hydrogen Sulfide Modulates Astrocytic Toxicity in Mouse Spinal Cord Cultures: Implications for Amyotrophic Lateral Sclerosis
    Susanna De Stefano, Marta Tiberi, Illari Salvatori, Marco De Bardi, Juliette Gimenez, Mahsa Pirshayan, Viviana Greco, Giovanna Borsellino, Alberto Ferri, Cristiana Valle et al. · 2024 · Antioxidants
  96. Cannabidiol Protects Against Neurotoxic Reactive Astrocytes‐Induced Neuronal Death in Mouse Model of Epilepsy
    Haojie Ye, Yuhui Wan, Xin Wang, Suji Wang, Xiansen Zhao, Xinshi Wang, Tianfu Yu, Chao Yan, Xin Tian, Zhang‐Peng Chen et al. · 2025 · Journal of Neurochemistry
  97. Reactive Nitrogen Species in Motor Neuron Apoptosis
    Mara Clara, G. Alvaro · 2012 · InTech eBooks
  98. Macrophage migration inhibitory factor as a component of selective vulnerability of motor neurons in ALS
    Salah Abu‐Hamad, Adrian Israelson · 2015 · Rare Diseases
  99. Amyotrophe Lateralsklerose
    Katja Kollewe, Reinhard Dengler, Susanne Petri · 2008 · Der Nervenarzt